Literature DB >> 12424268

Rhythmic properties of neurons in the rostral ventrolateral medulla of the rat in vitro: effects of clonidine.

Antonio R Granata1, Morton I Cohen.   

Abstract

The rostral ventrolateral medulla (RVLM) is thought to be the main central site for generation of tonic sympathetic activity. In the rat in vitro slice preparation, we used intracellular recordings to identify different populations of neurons in the RVLM: 43 spontaneously active neurons with regular (R) or irregular (I) patterns of spike firing and 10 silent neurons. The degree of regularity was quantified by the coefficient of variation (CV = SD/mean) of interspike interval durations, as well as by the rhythmic properties of the spike autospectrum and autocorrelation. The distribution of CVs was clustered: R and I neurons were defined as those with CVs </=12% (n = 21) or >12% (n = 22), respectively. The R-type and I-type neurons resemble the type II and type I neurons, respectively, which were previously characterized in the RVLM in vivo as barosensitive and bulbospinal. Both types may be important in generation of sympathetic tone. Clonidine (1-100 microM) was applied to 10 R-type neurons and 16 I-type neurons. The firing of 21/26 was depressed to the point of silence. However, 18/26 neurons were excited earlier in the perfusion. The later depression of firing occurred in both I and R neurons and in different cases was associated with either hyperpolarization or depolarization.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424268     DOI: 10.1152/jn.00085.2002

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  2 in total

1.  Modulatory inputs on sympathetic neurons in the rostral ventrolateral medulla in the rat.

Authors:  Antonio R Granata
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

Review 2.  A case report of clonidine induced syncope: a review of central actions of an old cardiovascular drug.

Authors:  Alexander J Sandweiss; Christopher M Morrison; Anne Spichler; John Rozich
Journal:  BMC Pharmacol Toxicol       Date:  2018-02-13       Impact factor: 2.483

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.